Canagliflozin Audit EASD Berlin 2018 - Abstract

2 year metabolic outcomes in the ABCD nationwide canagliflozin audit Author Block:

A. Puttanna1, M. Yadagiri1, P. Sen Gupta1, I. Gallen2, A. Bickerton3, S. Phillips4, A. Evans4, D. Sennik5, R. Ryder1

1Diabetes and Endocrinology, Sandwell and West Birmingham NHS Trust, Birmingham, UK

2Diabetes and Endocrinology, Royal Berkshire Hospitals NHS Trust, Berkshire, UK

3Diabetes and Endocrinology, Yeovil District Hospital NHS Trust, Yeovil, UK

4Diabetes and Endocrinology, Cheltenham General Hospital, Cheltenham, UK

5Diabetes and Endocrinology, Princess Alexandra Hospital, Harlow, UK.

Discipline: 
Diabetes
Clinical taxonomy: 
Treatments for diabetes
Type 2 diabetes mellitus
Resource taxonomy: 
Audit
Abstracts

Information for HCPs

COVID-19 Information for Healthcare Professionals